In this symposium, I will first briefly present our recent systematic review on the
cognitive effects of rTMS in depression, schizophrenia, and Alzheimer's disease, which
reviewed the preceding randomized controlled trials to examine the effectiveness of
rTMS administered to the dorsolateral prefrontal cortex (DLPFC) and evaluated cognitive
functions in these disorders. Second, I would like to talk about pathophysiology of
the DLPFC focused on the neuroplasticity as indexed by paired associative stimulation
(PAS) in patients with treatment-resistant depression using combined TMS-EEG technique.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Brain Stimulation: Basic, Translational, and Clinical Research in NeuromodulationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
465
Identification
Copyright
© 2018 Published by Elsevier Inc.
